Hoosier Cancer Research Network Clinical Trials
Sponsors / Hoosier Cancer Research Network
Hoosier Cancer Research Network appears as lead sponsor on 21 trial records in ClinicalTrials.gov. Of these, 2 are recruiting, 1 are active without new recruitment, and 9 have completed. The registry records 9 terminated or withdrawn trials for Hoosier Cancer Research Network. The most common reasons cited for termination include safety concerns, slow or insufficient recruitment, efficacy or futility findings. Planned participant enrollment across these trials sums to 1,179. Figures on this page are sourced from ClinicalTrials.gov and refreshed with each registry update.
21
Total Trials
2
Recruiting
1
Other Active
9
Completed
9
Terminated / Withdrawn
1,179
Total Enrollment
Termination reasons: Safety22% · Recruitment22% · Efficacy22% · Other22% · Funding11%
Recent Terminations
- Carcinoma, Unspecified Site"Study failed to meet its interim analysis endpoint"
- Bladder Carcinoma"Lack of Accrual"
- Bladder Cancer"Development of dovitinib was stopped."
- Genital Neoplasms, Female"Lack of Efficacy"
- Metastatic Prostate Cancer"Suspended by funder"
- Transitional Cell Carcinoma of the Bladder"Patient Toxicities"
- NCT00235235 Stopped Dec 2010Breast Cancer"Funding terminated"
- Multiple Myeloma"Study terminated due to low patient enrollment."
- Breast Cancer"Low patient enrollment; toxicities"
Active Trials (1 total)
- NCT05583708
- Neuroendocrine Tumors PHASE2NCT04848337
- Cutaneous T Cell Lymphoma PHASE2NCT05956041